The determinants of response to diltiazem in hypertension

Alexander M Shepherd, Carla LeForce, Glen D. Park, Robert S. Hoop, Scott Weir

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We examined factors (blood pressure, plasma renin activity, and age) influencing the antihypertensive response in essential hypertensive patients given 240 mg/day of slow-release diltiazem in an unblinded study after a placebo run-in period. Subjects provided a range of diastolic blood pressures (90 to 115 mm Hg), of age (31 to 70 years), and of plasma renin activity (0.1 to 2.7 ng angiotensin I/ml/hr) on a 70 to 150 mEq sodium diet. Blood pressure, plasma renin activity, and plasma diltiazem concentrations were measured after the first (n = 21) and final dose (n = 19) of 120 mg diltiazem, twice daily for 4 weeks. Multiple linear stepwise regression of change in blood pressure versus age, plasma renin activity, and baseline blood pressure showed baseline blood pressure was the only predictor of response (p = 0.0002). For each increase of 10 mm Hg in baseline pressure there was a 7 mm Hg greater decrease in diastolic blood pressure. We conclude that patient age and plasma renin activity are not clinically significant predictors of antihypertensive response to diltiazem in hypertension.

Original languageEnglish (US)
Pages (from-to)338-349
Number of pages12
JournalClinical Pharmacology and Therapeutics
Volume50
Issue number3
StatePublished - Sep 1991

Fingerprint

Diltiazem
Blood Pressure
Hypertension
Renin
Antihypertensive Agents
Angiotensin I
Linear Models
Sodium
Placebos
Diet
Pressure

ASJC Scopus subject areas

  • Pharmacology

Cite this

Shepherd, A. M., LeForce, C., Park, G. D., Hoop, R. S., & Weir, S. (1991). The determinants of response to diltiazem in hypertension. Clinical Pharmacology and Therapeutics, 50(3), 338-349.

The determinants of response to diltiazem in hypertension. / Shepherd, Alexander M; LeForce, Carla; Park, Glen D.; Hoop, Robert S.; Weir, Scott.

In: Clinical Pharmacology and Therapeutics, Vol. 50, No. 3, 09.1991, p. 338-349.

Research output: Contribution to journalArticle

Shepherd, AM, LeForce, C, Park, GD, Hoop, RS & Weir, S 1991, 'The determinants of response to diltiazem in hypertension', Clinical Pharmacology and Therapeutics, vol. 50, no. 3, pp. 338-349.
Shepherd AM, LeForce C, Park GD, Hoop RS, Weir S. The determinants of response to diltiazem in hypertension. Clinical Pharmacology and Therapeutics. 1991 Sep;50(3):338-349.
Shepherd, Alexander M ; LeForce, Carla ; Park, Glen D. ; Hoop, Robert S. ; Weir, Scott. / The determinants of response to diltiazem in hypertension. In: Clinical Pharmacology and Therapeutics. 1991 ; Vol. 50, No. 3. pp. 338-349.
@article{5ebc45e6419348ba96359004ff23eab8,
title = "The determinants of response to diltiazem in hypertension",
abstract = "We examined factors (blood pressure, plasma renin activity, and age) influencing the antihypertensive response in essential hypertensive patients given 240 mg/day of slow-release diltiazem in an unblinded study after a placebo run-in period. Subjects provided a range of diastolic blood pressures (90 to 115 mm Hg), of age (31 to 70 years), and of plasma renin activity (0.1 to 2.7 ng angiotensin I/ml/hr) on a 70 to 150 mEq sodium diet. Blood pressure, plasma renin activity, and plasma diltiazem concentrations were measured after the first (n = 21) and final dose (n = 19) of 120 mg diltiazem, twice daily for 4 weeks. Multiple linear stepwise regression of change in blood pressure versus age, plasma renin activity, and baseline blood pressure showed baseline blood pressure was the only predictor of response (p = 0.0002). For each increase of 10 mm Hg in baseline pressure there was a 7 mm Hg greater decrease in diastolic blood pressure. We conclude that patient age and plasma renin activity are not clinically significant predictors of antihypertensive response to diltiazem in hypertension.",
author = "Shepherd, {Alexander M} and Carla LeForce and Park, {Glen D.} and Hoop, {Robert S.} and Scott Weir",
year = "1991",
month = "9",
language = "English (US)",
volume = "50",
pages = "338--349",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - The determinants of response to diltiazem in hypertension

AU - Shepherd, Alexander M

AU - LeForce, Carla

AU - Park, Glen D.

AU - Hoop, Robert S.

AU - Weir, Scott

PY - 1991/9

Y1 - 1991/9

N2 - We examined factors (blood pressure, plasma renin activity, and age) influencing the antihypertensive response in essential hypertensive patients given 240 mg/day of slow-release diltiazem in an unblinded study after a placebo run-in period. Subjects provided a range of diastolic blood pressures (90 to 115 mm Hg), of age (31 to 70 years), and of plasma renin activity (0.1 to 2.7 ng angiotensin I/ml/hr) on a 70 to 150 mEq sodium diet. Blood pressure, plasma renin activity, and plasma diltiazem concentrations were measured after the first (n = 21) and final dose (n = 19) of 120 mg diltiazem, twice daily for 4 weeks. Multiple linear stepwise regression of change in blood pressure versus age, plasma renin activity, and baseline blood pressure showed baseline blood pressure was the only predictor of response (p = 0.0002). For each increase of 10 mm Hg in baseline pressure there was a 7 mm Hg greater decrease in diastolic blood pressure. We conclude that patient age and plasma renin activity are not clinically significant predictors of antihypertensive response to diltiazem in hypertension.

AB - We examined factors (blood pressure, plasma renin activity, and age) influencing the antihypertensive response in essential hypertensive patients given 240 mg/day of slow-release diltiazem in an unblinded study after a placebo run-in period. Subjects provided a range of diastolic blood pressures (90 to 115 mm Hg), of age (31 to 70 years), and of plasma renin activity (0.1 to 2.7 ng angiotensin I/ml/hr) on a 70 to 150 mEq sodium diet. Blood pressure, plasma renin activity, and plasma diltiazem concentrations were measured after the first (n = 21) and final dose (n = 19) of 120 mg diltiazem, twice daily for 4 weeks. Multiple linear stepwise regression of change in blood pressure versus age, plasma renin activity, and baseline blood pressure showed baseline blood pressure was the only predictor of response (p = 0.0002). For each increase of 10 mm Hg in baseline pressure there was a 7 mm Hg greater decrease in diastolic blood pressure. We conclude that patient age and plasma renin activity are not clinically significant predictors of antihypertensive response to diltiazem in hypertension.

UR - http://www.scopus.com/inward/record.url?scp=0025940818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025940818&partnerID=8YFLogxK

M3 - Article

C2 - 1914368

AN - SCOPUS:0025940818

VL - 50

SP - 338

EP - 349

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 3

ER -